Actemra and Eye movements - uncontrollable - a phase IV clinical study of FDA data

Summary:

Eye movements - uncontrollable is reported as a side effect among people who take Actemra (tocilizumab), especially for people who are male, 50-59 old, have been taking the drug for 1 - 2 years also take Advair Hfa,.

The phase IV clinical study analyzes which people have Eye movements - uncontrollable when taking Actemra. It is created by eHealthMe based on reports of 102,551 people who have side effects when taking Actemra from the FDA, and is updated regularly.

What is Actemra?

Actemra has active ingredients of tocilizumab. It is often used in rheumatoid arthritis. eHealthMe is studying from 102,759 Actemra users. Check the latest studies of Actemra.

What is Eye movements - uncontrollable?

Eye movements - uncontrollable is found to be associated with 524 drugs and 1,512 conditions by eHealthMe. Check the latest studies of Eye movements - uncontrollable.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 30, 2026

102,551 people reported to have side effects when taking Actemra.
Among them, 11 people (0.01%) have Eye movements - uncontrollable.

Could Actemra cause Eye movements - uncontrollable?

Among these 11 people:

How long have people been on Actemra when they have Eye movements - uncontrollable? *

What is the gender of people who have Eye movements - uncontrollable when taking Actemra? *

female: 0.0 %
male: 100 %

What is the age of people who have Eye movements - uncontrollable when taking Actemra? *

What are other drugs people take besides Actemra? *

What are other side effects people have besides Eye movements - uncontrollable? *

Nausea (feeling of having an urge to vomit): 10 people, 90.91%
Dizziness: 10 people, 90.91%
Wound Infection: 9 people, 81.82%
Fatigue (feeling of tiredness): 9 people, 81.82%
Joint Swelling: 9 people, 81.82%
Weight Increased: 9 people, 81.82%
Infusion Related Reaction: 9 people, 81.82%
Infection: 9 people, 81.82%
Hypoaesthesia Oral (reduced sense of touch or sensation in mouth): 9 people, 81.82%
High Blood Pressure: 9 people, 81.82%

* Approximation only. Some reports may have incomplete information.

Do you take Actemra and have Eye movements - uncontrollable?

- Check whether Eye movements - uncontrollable is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Actemra:

Actemra (102,759 reports)

Browse all side effects of Actemra:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Eye movements - uncontrollable:

Eye movements - uncontrollable (524 drugs)

Browse all the conditions that are associated with Eye movements - uncontrollable:

Eye movements - uncontrollable (1,512 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on tocilizumab (the active ingredients of Actemra) and Actemra (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.